Speaker Profile
Co-Founder & CEO, OneCell Dx
Biography
Mohan Uttarwar is an accomplished entrepreneur and innovator with extensive expertise in life sciences and precision diagnostics. With a strong track record of building successful companies, he has pioneered advancements in healthcare through innovative technologies and transformative solutions. Mohans work focuses on addressing unmet needs in oncology and personalized medicine, leveraging cutting-edge platforms to improve patient outcomes.As a visionary leader, he excels in driving strategic growth, fostering collaborations, and guiding teams to achieve breakthrough results. His contributions have significantly influenced the development of next-generation diagnostic tools, particularly in the areas of liquid biopsy and multiomics.Mohan remains committed to advancing healthcare by bridging the gap between scientific discovery and clinical application, creating impactful solutions for patients and healthcare providers worldwide.
Talk
Cell Biopsy A.I. Shaping the Future of Precision Oncology
Discover how Cell Biopsy and Artificial Intelligence are revolutionizing Precision Oncology. This talk highlights innovations in liquid biopsy, single-cell analysis, and AI-powered insights, driving real-time tumor profiling and personalized therapies. Gain insights into how these technologies will shape cancer care and advance treatment outcomes.
Clinical Dx Showcase:
OneCell Dx
OneCell Diagnostics is a Precision Oncology company revolutionizing cancer care through advanced liquid biopsy solutions. Its cutting-edge platform integrates single-cell multiomics to deliver real-time tumor insights, empowering personalized therapies and accelerating breakthroughs in clinical research.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
